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A nominal group technique was employed involving palliative care researchers attending a 
workshop within a scientific meeting on prognostication. Participants worked in small 
facilitated groups to generate future research questions which were amalgamated and rated 
according to importance.  
 
Results 
Twenty-five meeting delegates took part in the workshop including 10 palliative care 
physicians and four nurses, one dietician, and 10 academic researchers, all of whom had 
experience and/or interest in prognosis research. A total of 40 research questions were 
generated and after prioritisation ratings, the top five questions were: 1) How valid are 
prognostic tools? =2) Can we use prognostic criteria as entry criteria for research? =2) How 
do we judge the impact of a prognostic score in clinical practice? 4) What is the best way of 
presenting survival data to patients? 5) What is the most user-friendly validated tool? 
 
Conclusions 
Although a wide range of research questions relating to prognostication were identified, the 
strongest priority to emerge from the consensus data concerned the validity of prognostic 




Prognostication, the prediction of the course or outcome of a disease, has various purposes. 
In the clinical context it is used to inform
 
individuals about the future course of illness and to 
guide treatment decision-making. At a personal level it aids patients in organising their affairs 
at the end of life. In policy terms it can determine eligibility for relevant benefits or access to 
resources. In research settings prognostic estimates may be used to select relevant patients 
for particular studies. Recently, we have also seen how prognostication can be involved in 
political decisions with the case of Abdelbaset Ali al-Megrahi. The convicted Lockerbie 
bomber was released from prison on compassionate grounds when estimated to have three 




However, despite the wide use of prognostic estimates, accurate predictions are notoriously 
difficult. Subjective approaches based on doctors’ clinical judgement have low correlations 
with actual outcomes.
2
 A comparison of physician estimates and actual survival times for 300 
terminally-ill patients with cancer showed a significant discrepancy (median of 75 days versus 
26 days).
3
 More objective approaches involve the use of actuarial data to make predictions 
from single variables (e.g. performance status, presence of symptoms, or laboratory 
parameters) or combinations of factors. Although numerous formal prediction tools have been 
developed, most are not adequately validated, and are unreliable in practice.
4
 Given the 
important implications of prognostication for patient care and policy, there is a clear need for 
carefully designed research on this subject.  
 
The Cancer Experiences Collaborative (CECo) Methodology theme organised a State of the 
Science meeting on prognostication within supportive and palliative care in order to bring 
together health professionals and researchers to discuss the current state of the evidence in 
prognostication and the future research agenda. An afternoon workshop was arranged using 




Twenty-five delegates took part in the workshop. These included ten palliative care 
physicians, four nurses, one dietician and ten academic researchers. All had involvement in 
palliative care research and experience and/or interest in the subject of prognostication. 
 
Design 
A nominal group technique was used for eliciting and ranking research questions in order to 
establish a level of consensus on future priorities. Nominal group techniques have a long 
history of use in health and medicine, providing a structured format for discussion and 






The meeting involved presentations by five experienced researchers within the 
prognostication area (Table 1) each followed by an open discussion among delegates. 
Subsequently, workshop participants were allocated to four facilitated groups of 6-7 people. 
Facilitators asked participants to spend 10 minutes individually writing down potential 
research questions relating to prognostication based on what they had learnt from the 
presentations and their own experiences. These were reported one by one to the facilitator 
who wrote them all on a flipchart. Group discussion was then initiated to clarify and rephrase 
questions where necessary. The lists of questions from the four groups were amalgamated, 
duplicate items were removed, and the final list was presented to all individuals. Participants 
were asked to score up to ten items according to perceived importance with the highest 
priority scored 10, the second highest 9, and so on.  
 
Analysis 
Scores from all participants were summed for each question and totals sorted into descending 
order. The maximum possible score for questions was 250 (25 participants scoring 10). In 
three instances, two questions were deemed to address an identical topic. In the first two 
cases (Q16/Q28 and Q20/Q35), all participants had rated one or the other item, but not both, 
allowing the two totals to be summed. In the third case (Q23/Q40), the same procedure was 
used except with three participants who had rated both items and a mean of the two scores 
was used.  
 
RESULTS 
A total of forty research questions were generated between the four groups (Table 2) and 
were presented to all participants for ranking. Totals were calculated for all questions and the 
highest 15 are presented in Figure 1. Five questions emerged as having distinctly higher 
scores than the others and these priority questions are presented in Table 3. 
 
DISCUSSION 
The aim of the prioritisation exercise was to establish a consensus among a group of 
palliative care clinicians and researchers on the most important questions to be addressed 
relating to prognostication.   
 
The highest priority question that emerged relates to the validity of prognostic tools. This is 
clearly vital with regard to the clinical value of such instruments. Although a particular model 
might successfully predict outcomes in one sample of patients, this is of little real use if it does 
not also do so in other samples.
6
 There are many cases in the literature of prognostic tools 
that have been developed but not adequately validated.
7
 However, there are also examples of 




 and the Palliative Prognostic Score.
11-14
  Nonetheless, the reviews of 
the state of the science of prognostication presented at the meeting, clearly revealed the need 
for further development and validation of tools to assist clinicians in their prognostic decision 
making.  
 
One example of ongoing research to develop and validate a prognostic tool is the Prognosis 
in Palliative Care Study (PIPS).
15
 PIPS aims to develop a new prognostic index to improve, or 
possibly replace, clinician estimates of survival for palliative care patients. PIPS also aims to 
determine whether repeated prognostic assessments are more accurate than single 
assessments and to determine whether self-reported symptom severity provides better 
prognostic accuracy than observer-rated symptom severity in competent palliative care 
patients. PIPS is a prospective multicentre observational study of consecutive eligible 
referrals to participating palliative care units and collects a range of socio-demographic, 
clinical, performance and self-report measures that have been demonstrated to be predictors 
or possible predictors of survival. Recruitment closed at the end of July 2009, and analysis is 
underway at time of writing. Ultimately it is envisaged that the resulting instrument will be 
used in clinical practice to aid decision-making.  
 
The next two highest ranked research questions received equal scores. One was directly 
research oriented (use of prognostic scores as eligibility criteria for research) and the other an 
applied issue (the impact of a prognostic score on clinical practice).  
 
Obtaining a well-defined sample is one of the challenges of research in palliative care. A 
comparison of hospital doctors and general practitioners indicated a discrepancy in 20% of 
cases regarding the palliative status of patients.
16
 Many studies involving patients at the end 
of life rely on physician judgement for determining eligibility. The inherent variability in the 
accuracy of these judgements can lead to participants dying earlier than expected and not 
completing the study, or in other cases surviving longer than expected and retrospectively 
proving ineligible.
17
 If the use of more objective criteria (i.e. a prognostic score from a 
validated tool) provides more reliable entry criteria it would lead to an enhancement of the 
overall quality of palliative care studies.  
 
Evaluating the impact of a prognostic score on clinical practice is of clear importance since 
there would be little value in developing and validating tools if they do not lead to 
improvements in practice. Impact may be measured in terms of physician decision-making, 
patient outcome, and cost-effectiveness.
18
 The potential value of using a predictive tool 
depends on how its predictions are translated into decisions that are applied to patient care. 
Despite the large number of predictive tools developed within different healthcare domains, 
few have been formally evaluated in impact studies and implemented in daily practice. Recent 




help in the development and assessment of prognostic tools that will ultimately lead to greater 
quality and cost-effectiveness of care. 
 
The fourth priority concerned the best way of presenting survival data to patients. Existing 
research indicates that patients vary in the degree of detail desired from their doctors 
regarding their prognosis, and do not always fully comprehend the information given.
20 21
 The 
risk is that incomplete understanding can lead to sub-optimal decision-making by patients and 
subsequently poor outcomes. In one study, patients who believed they had at least a 90% 
chance of living for ≥6 months were more than twice as likely to favour life-extending therapy 
over palliative care than those who thought they were less likely to live that long. However, 
adjusted analyses revealed no difference in 6-month survival between the two groups, while 
those choosing life-extending therapy were more likely to experience adverse events (e.g. 




 These findings 
suggest that improving patient understanding of their prognosis may help avoid unnecessary 
suffering
 
at the end of life.  
 
A study of the information preferences of patients with metastatic cancer found that 
information presented as words and numbers were favoured over charts or graphs, with over 
80% wanting to know statistical information (e.g. longest survival time with treatment, 5-year 
survival rates, and average survival).
23
 The optimal ways of communicating such information 
have not been determined. There is a body of research exploring the effects of information 
framing on patient decisions. One widely cited study found that participants were more likely 
to opt (hypothetically) for a riskier treatment option (surgery over radiation) for lung cancer 
when presented in a positive frame (e.g. 90% chance of survival) than a negative frame (e.g. 
10% chance of mortality).
24
 However, a review of similar studies found no consistent pattern 
of patient decision-making based on how information was framed.
25
 In an interview study with 
health professionals, doctors reported that they tried to provide survival estimates as ranges 
or proportions in lay language to avoid patients focussing on absolute figures and to maintain 
the right mix of realism and hope.
26
 Clinical practice guidelines for prognostic and end-of-life 
communication have been published based on existing evidence.
27
 However, the reliance on 
expert opinion in places where research was lacking highlights the need for investigation of 
this important subject. 
 
The fifth priority identified relates to identifying the most user-friendly validated tool. This links 
directly with the first priority of validating tools. Many simple predictive indices or nomograms 
exist that are undoubtedly user-friendly, but may not have been formally validated. Equally, a 
model with high reliability and validity may not be useful in practice if it is difficult or time-
consuming to administer or interpret by busy clinicians. A systematic review of ten prognostic 
tools in palliative care found the validity data promising for several instruments.
28
 However 
some tools were burdensome to use due to the large number of variables to take into account 
 7 
or the need for laboratory tests. Furthermore, continued research to refine tools may identify 
additional variables or suggest that repeated measures are necessary to improve predictive 
accuracy which would further increase the complexity of the task. One of the challenges in 
developing and validating predictive tools is ensuring that they are also sufficiently user-
friendly to be of practical value. 
 
Establishing consensus among a particular group of individuals on an issue is not an attempt 
to provide a ‘correct’ answer. Rather it is a systematic way of identifying current opinion and 
areas of disagreement.
29
 The twenty-five delegates taking part in the current task are not 
necessarily representative of the nation’s experts in this area, and it is important to recognise 
that a different group of prognostication researchers may have produced an alternative set of 
priorities. However, the participants did represent a broad range of disciplines, levels of 
research and clinical experience and seniority, and a broad geographical spread. The 
presentations and discussions which preceded the consensus exercise may also have had 
important effects on the judgments of the members of the groups. The presentations provided 
overviews of the state of the science from recognised experts in the field. Inevitably these 
experts will have highlighted specific issues based on their knowledge and experience. And 
the ensuing discussions were inevitably led by individuals with specific views, although 
chairing ensured an open debate. Whether this consensus procedure introduces bias, as 
opposed to simply being informed debate, is of course an issue for all consensus methods. 
This can be partially guarded against through transparency of the consensus decision-making 
process and clarity of evidence presented. In the present case transparency has been 
ensured by following standard procedures and reporting them openly, and by making the 




None of the research questions came close to receiving unanimous maximum ratings (i.e. a 
score of 250) and the small difference between the total scores of the top five items indicates 
that no questions were considered of outstanding priority. Instead, several issues of broadly 
similar importance emerged. Undoubtedly, prognostication is a complex subject with 
implications within several diverse domains (e.g. personal, clinical, policy, research).  
 
In summary, a wide range of research questions relating to prognostication were identified, 
but the strongest priority to emerge from the consensus data concerned the validity of 
prognostic tools. The importance of this issue lies in the ability of a measure to accurately 
predict outcomes beyond the original sample, in order that it can have wider clinical value. 
The ongoing PIPS study is a good example of an attempt to develop and validate a 
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Q1 How variable is validity between centres? 
Q2 How do we judge the impact of a prognostic score in clinical practice? 
Q3 Is choice of death important in prognostic indices? 
Q4 Is socioeconomic status important to prognosis predictions? 
Q5 How valid are prognostication tools? 
Q6 What is the most user-friendly validated tool? 
Q7 Are there psychosocial or spiritual factors that influence prognosis? 
Q8 Does ‘tone’ of care influence prognosis for older people with dementia? 
Q9 Could prognostic tools be adapted for children? 
Q10 Are the Gold Standard Framework prognostic indicators validated? 
Q11 Can prognostication tools be used in non-cancer populations? 
Q12 Could prognostication tools be used as a trigger to initiate palliative care referral? 
Q13 Can downstream tools be used upstream? 
Q14 What sentinel physical or emotional events alter prognosis? 
Q15 How do prognosis estimates differ between clinicians, carers, and patients? 
Q16 What do clinicians use to estimate prognosis? [combined with Q28] 
Q17 How do we increase awareness in non-palliative care physicians? 
Q18 Does being given prognosis information increase/decrease survival? 
Q19 What is the optimum time period to measure change for prediction? 
Q20 Can we use prognostic scores as entry criteria for research? [combined with Q35] 
Q21 What are the main disease trajectories? 
Q22 How do the predictions of different grades of professionals and multi-disciplinary 
teams compare in relation to survival? 
Q23 What are the preferred methods of presenting information to patients and others? 
[combined with Q40]  
Q24 How do prognosis predictions influence patient views? 
Q25 How does the understanding and priorities of patients change over time? 
Q26 What is the impact of prognosticating on patients, outcomes, costs, and service 
delivery? 
Q27 What are the experiences of patients in the disclosure of prognosis? 
Q28 What are clinicians considering when they make prognostic judgements? 
[combined with Q16] 
Q29 Would the routine use of a prognostic tool in hospice settings affect informed 
communication? 
Q30 Does improving symptoms lead to changes in prognosis? 
Q31 What are the information needs of patients and families regarding survival 
predictions? 
Q32 What other health outcomes beyond survival do palliative care patients rate as 
important? 
Q33 How well do tools compare with clinical judgements? 
Q34 Would it be possible to predict disease stage? 
Q35 Can prognostic models be used to determine research study eligibility criteria? 
[combined with Q20] 
Q36 What are the risks/benefits for patients and health-care professionals of 
disclosing prognosis? 
Q37 What do patients really mean when they ask ‘how long do I have?’ 
Q38 Who wants to know about prognosis and why? 
Q39 Do predictive models change clinical decisions? 





Table 3. Five research priorities emerging from consensus exercise 
 
Rank Research question Score 
  1 How valid are prognostic tools? (Q5) 83 
=2 Can we use prognostic criteria as entry criteria for research? (Q2) 79 
=2 How do we judge the impact of a prognostic score in clinical practice? (Q16) 79 
  4 What is the best way of presenting survival data to patients? (Q23) 73.5 
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